MALDI-TOF MALDI-TOF Mass Spec Approach Can Predict Antimicrobial Resistance in Clinical Samples A Swiss team said the mass spectrometry- and machine learning-based approach could help guide clinical treatment choices. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome. At ASMS 2017, Vendors Focus on Software, Applications Premium With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms. MALDI-Based Fatty Acid Profiling Offers Infectious Disease Dx Potential Premium Scientists from the Colorado School of Mines have proposed a method to complement mass spec-based protein profiling. Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation Premium While much attention has focused on triple quads, MALDI-TOFs offer advantages in simplicity and throughput that could help them make clinical inroads. May 14, 2015 Map Diagnostics Developing Mass Spec Test for Down Syndrome Premium Apr 29, 2015 Swedish Researchers Use MALDI-TOF to Type Clostridium Difficile Jul 19, 2013 MALDI Mass Spec Poised for Further Expansion into Clinical Microbiology Market Pending FDA Approvals Premium Jan 28, 2013 Ezose Sciences, Kyowa Hakko Ink Glycomics Pact Jan 3, 2013 Bruker Licenses IP from Erasmus Medical Center Mar 2, 2012 Biodesix Inks Deal to Test Veristrat in Phase III Clinical Trial for Kadmon Lung Cancer Drug Premium Jan 20, 2012 New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform Premium Dec 9, 2011 Glycomics Firm Ezose Inks Deal with Merck for Diabetes Biomarker Work Premium Dec 1, 2011 Bruker, Chungnam National University Partner on Glycan Analysis Aug 26, 2011 Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec Premium Aug 19, 2011 Proteomics Technologies Making Their Way into Pathogen Detection Premium May 6, 2011 Michigan Researchers ID Potential Glycoprotein Biomarker for Pancreatic Cancer Premium Apr 8, 2011 Top-Down Proteomics Inching Its Way Toward the Mainstream Premium Jan 21, 2011 Q&A: Oncologist Cristobal Belda-Iniesta on Proteomics' Role in Improving Cancer Treatments Premium Nov 5, 2010 Q&A: Metropolitan Museum of Art's Julie Arslanoglu on Proteomics in Art History and Conservation Premium Dec 3, 2009 Germany's Synlab to Use Bruker Mass Spec Tech for Microbial Identification Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.